FibroBiologics, Inc. Common Stock (FBLG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.57M
Last updated: Nov 17, 2026 at 11:01 AM ET
FibroBiologics, Inc. Common Stock (FBLG) Stock Forecast
Analysts expect FibroBiologics, Inc. Common Stock (FBLG) to earn -$3.00 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$3.25.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Dec 31, 2026
- -$3.00
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$3.25
- EPS consensus
- Next report
- Feb 22, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$3.00 | -$3.00 to -$3.00 | 1 |
| Dec 31, 2027 | -$3.25 | -$3.25 to -$3.25 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.64 | N/A | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.00 | -$4.01 | -$4.01 | -$4.01 | -$3.71 | N/A |
| Fiscal year ending Dec 31, 2027 | -$3.25 | -$4.49 | -$4.49 | -$4.49 | -$3.85 | N/A |
Frequently Asked Questions About FBLG
What is the FBLG stock forecast?
Consensus analyst estimates put FibroBiologics, Inc. Common Stock's EPS at -$3.00 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from FBLG next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.00, with estimates from -$3.00 to -$3.00 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.25, with estimates from -$3.25 to -$3.25 from 1 analyst.
How many analysts cover FBLG?
1 analyst estimates EPS for FibroBiologics, Inc. Common Stock for the fiscal year ending Dec 31, 2026.
FBLG pages: Overview, Earnings, Forecast, Financials, Competitors